Mandate

Vinge advises Varyag Resources

May 11, 2009

Vinge has advised Varyag Resources AB (publ) listed on First North in connection with a restructuring of Varyag Resources which entails a change of strategy and structure from a private equity to a forestry company.

The reconstruction entails an acquisition of 50 per cent of the shares in RusForest Ltd and of receivables against RusForest amounting to approximately MRUB 800 from a wholly-owned subsidiary of Vostok Nafta Investment Ltd. Payment will be made in the form of newly-issued shares in Varyag Resources to an estimated value at the time of contracting of approximately SEK 156 million.

Vinge’s team primarily consisted of partners Göran Nyström and Malin Leffler together with, among others, associates Jonas Johansson and Andreas Wirén.

Related

Vinge has advised Course Corrected VC on the establishment of Course Corrected VC Fund II

Vinge has advised Course Corrected VC on the establishment and structuring of their second fund, Course Corrected VC Fund II (the “Fund”).
November 12, 2026

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026